Results 231 to 240 of about 1,045,655 (263)
Some of the next articles are maybe not open access.

Ponatinib: A Review of Efficacy and Safety

Current Cancer Drug Targets, 2018
Ponatinib is a third generation kinase inhibitor designed to overcome the gatekeeper T315I mutation. In different trials this drug showed inhibitory activity against native BCR-ABL1 kinase and several ABL1 mutations. For this reason, ponatinib is currently indicated for the treatment of chronic myeloid leukaemia (CML) in every phase of disease ...
Massaro F, Molica M, Breccia M
openaire   +3 more sources

Pixantrone: merging safety with efficacy

Expert Review of Hematology, 2013
Pixantrone is a novel anthracycline derivative, manufactured by Cell Therapeutics Incorporated, WA, USA. It was developed with the aim to retain the efficacy of anthracyclines and be less cardiotoxic. Initial safety trials and single-arm, Phase II trials have shown preliminary evidence of anticancer activity and manageable toxicity.
Dionysios, Papadatos-Pastos   +1 more
openaire   +2 more sources

Concentrate safety and efficacy

Haemophilia, 2002
Safety from transmission of infections through plasma‐derived clotting factor concentrates is assured by improved donor screening, serological testing of individual donations and direct viral testing of small plasma pools. Modern viral‐inactivation techniques are highly effective.
openaire   +2 more sources

Efficacy and Safety of Percutaneous Epiphysiodesis

Journal of Pediatric Orthopaedics, 2008
The aims of this study were to evaluate outcomes of percutaneous epiphysiodesis, as described by Bowen, in 97 patients and to assess complications and determine whether the effect of the epiphysiodesis will accurately follow the Moseley chart predictions.A total of 97 patients were reviewed retrospectively.
Muharrem, Inan   +4 more
openaire   +2 more sources

Metrifonate: Overview of Safety and Efficacy

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1998
Metrifonate is a cholinesterase inhibitor with a long‐lasting inhibition that raises brain acetylcholine levels. It is well‐absorbed and has limited binding to serum proteins. In preliminary studies of its utility in the treatment of Alzheimer disease's (AD), it led to improvements of cognition or reduced the rate of decline of cognition compared with ...
openaire   +2 more sources

Safety and Efficacy of Leadless Pacemakers: A Systematic Review and Meta‐Analysis

Journal of the American Heart Association, 2021
Linh Ngo, Daniel Nour, Russell Denman
exaly  

The Safety and Efficacy of Phage Therapy: A Systematic Review of Clinical and Safety Trials

Antibiotics, 2022
Helen J Stacey   +2 more
exaly  

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines

Molecular Therapy, 2021
Yinghui Peng, Ping Liu, Cao Guo
exaly  

COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials

Pharmaceuticals, 2021
Zhipeng Yan   +2 more
exaly  

Home - About - Disclaimer - Privacy